(Q40599458)

21 September 2017

Inhibition of Plasmodium falciparum proliferation in vitro by antisense oligodeoxynucleotides against malarial topoisomerase II. (English)

1 reference

21 September 2017

Plasmodium falciparum

0 references

malaria

0 references

author name string

Wilai Noonpakdee

1

1 reference

21 September 2017

Jinrapa Pothikasikorn

2

1 reference

21 September 2017

Wirat Nimitsantiwong

3

1 reference

21 September 2017

Prapon Wilairat

4

1 reference

21 September 2017

1 March 2003

1 reference

Biochemical and Biophysical Research Communications

21 September 2017

1 reference

21 September 2017

302

1 reference

21 September 2017

4

1 reference

21 September 2017

659-664

1 reference

Malaria: Current status of control, diagnosis, treatment, and a proposed agenda for research and development

21 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900246-8

Malaria, the submerged disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900246-8

7 January 2021

The treatment of malaria

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900246-8

Molecular cloning and sequence analysis of the Plasmodium falciparum dihydrofolate reductase-thymidylate synthase gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900246-8

Sequence variation of the hydroxymethyldihydropterin pyrophosphokinase: dihydropteroate synthase gene in lines of the human malaria parasite, Plasmodium falciparum, with differing resistance to sulfadoxine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900246-8

Point mutations in the dihydrofolate reductase-thymidylate synthase gene and pyrimethamine and cycloguanil resistance in Plasmodium falciparum.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900246-8

Current concepts in antisense drug design

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900246-8

Antisense oligodeoxynucleotides as clinical therapeutic agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900246-8

Antisense-oligonucleotide therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900246-8

Review of in vivo pharmacokinetics and toxicology of phosphorothioate oligonucleotides.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900246-8

Antimalarial activities of oligodeoxynucleotide phosphorothioates in chloroquine-resistant Plasmodium falciparum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900246-8

Inhibition of Plasmodium falciparum malaria using antisense oligodeoxynucleotides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900246-8

Antisense oligonucleotides targeting malarial aldolase inhibit the asexual erythrocytic stages of Plasmodium falciparum.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900246-8

Does antisense make sense?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900246-8

Structure and mechanism of DNA topoisomerase II

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900246-8

Structure of DNA topoisomerases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900246-8

DNA topoisomerase poisons as antitumor drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900246-8

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900246-8

Synthesis and in vitro evaluation of 9-anilino-3,6-diaminoacridines active against a multidrug-resistant strain of the malaria parasite Plasmodium falciparum.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900246-8

Structure-activity relationships and modes of action of 9-anilinoacridines against chloroquine-resistant Plasmodium falciparum in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900246-8

In vitro study of anticancer acridines as potential antitrypanosomal and antimalarial agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900246-8

Cleavage of DNA induced by 9-anilinoacridine inhibitors of topoisomerase II in the malaria parasite Plasmodium falciparum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900246-8

The gene encoding topoisomerase II from Plasmodium falciparum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900246-8

Resistance of ten Thai isolates of Plasmodium falciparum to chloroquine and pyrimethamine by in vitro tests

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900246-8

Human malaria parasites in continuous culture

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900246-8

Synchronization of Plasmodium falciparum Erythrocytic Stages in Culture

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900246-8

Flow cytometric assessment of hydroxypyridinone iron chelators on in vitro growth of drug-resistant malaria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900246-8

Quantitative assessment of antimalarial activity in vitro by a semiautomated microdilution technique

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900246-8

Inhibition of Plasmodium falciparum proliferation in vitro by ribozymes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900246-8

Non-sequence-specific antimalarial activity of oligodeoxynucleotides.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900246-8

Anti-sense oligodeoxynucleoside phosphorothioates nonspecifically inhibit invasion of red blood cells by malaria parasites.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900246-8

Blocking of the receptor-mediated invasion of erythrocytes by Plasmodium knowlesi malaria with sulfated polysaccharides and glycosaminoglycans.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900246-8

Malaria merozoite surface protein antisense oligodeoxynucleotides lack antisense activity but function as polyanions to inhibit red cell invasion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900246-8

Intraerythrocytic expression of topoisomerase II from Plasmodium falciparum is developmentally regulated

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900246-8

Antisense oligonucleotides: towards clinical trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900246-8

Direct access to serum macromolecules by intraerythrocytic malaria parasites

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900246-8

10.1016/S0006-291X(03)00246-8

7 January 2021

Identifiers

DOI

1 reference

release_6znrsdoj2bbs5kqijuk3ynhfty

21 September 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/6znrsdoj2bbs5kqijuk3ynhfty

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference